PAVmed Investor Relations - Press Releases

Investor Relations

Press Releases

Month Year

Email Alerts

Nov 9, 2017

PAVmed Inc. to Hold Business Update Conference Call on November 16th

NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (NASDAQ:PAVM; PAVMW), a highly differentiated, multi-product medical device company, today announced that the Company will host a conference call on...
Oct 10, 2017

PAVmed to Present at Dawson James Securities 3rd Annual Small Cap Growth Conference

NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (NASDAQ:PAVM; PAVMW), a highly differentiated, multi-product medical device company, today announced that Dennis McGrath, PAVmed’s Chief Financial...
Sep 18, 2017

PAVmed to Present at the Cantor Fitzgerald Global Healthcare Conference

NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (NASDAQ:PAVM; PAVMW), a highly differentiated, multi-product medical device company, today announced that Lishan Aklog, M.D., PAVmed’s Chairman and Chief...
Aug 14, 2017

PAVmed Reports Second Quarter 2017 Financial Results

Conference call to be held August 17, 2017 at 4:30 p.m. Eastern time

NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multiproduct medical device company, today announced financial results for the three and six months ended...
Aug 9, 2017

PAVmed Inc. to Hold Business Update Conference Call on August 17th

NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (NASDAQ:PAVM; PAVMW), a highly differentiated, multi-product medical device company, today announced that the Company will host a conference call on...
Jul 5, 2017

PAVmed Inc. Closes $5 Million Financing

NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced the closing of a $5 million financing provided by...
Jun 23, 2017

PAVmed Announces Effectiveness of Form S-1 Resale Registration Statement

NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multiproduct medical device company, today announced that on June 23, 2017, the Securities and Exchange...
Jun 22, 2017

PAVmed to Join Russell Microcap® Index

NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multiproduct medical device company, today announced that the Company will join the Russell Microcap® Index...
May 22, 2017

PAVmed Reports First Quarter 2017 Financial Results and Provides Business Update

Conference call to be held May 31, 2017 at 4:30 p.m. Eastern time

NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multiproduct medical device company, today announced financial results for the three months ended March 31,...
May 16, 2017

PAVmed Inc. Postpones Business Update Conference Call to May 31st

NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (NASDAQ:PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced that the Company will postpone its business update...
May 10, 2017

PAVmed Inc. to Hold Business Update Conference Call on May 17th

NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (NASDAQ:PAVM; PAVMW), a highly differentiated, multi-product medical device company, today announced that the Company will host a conference call on May 17,...
Apr 10, 2017

PAVmed Announces Filing of Exchange Offer Registration Statement with the SEC

Exchange Structured to Reward Current Security Holders and Incentivize Long-term Ownership by Both Existing and New Investors

NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced that it filed a registration statement on Form S-4...
Mar 31, 2017

PAVmed Announces Revised Presentation Time at the 16th Annual Needham Healthcare Conference

Company Presentation Set for April 4th at 12:50 p.m. ET

NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVM)(Nasdaq:PAVMW), a highly differentiated, multi-product medical device company, today announced a revised time for the Company’s presentation...
Mar 28, 2017

PAVmed Announces Filing of Registration Statement Relating to Private Placement

No Securities Available for Resale Prior to Effectiveness and Nasdaq-related Approvals

NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced that the Company has filed a registration statement on...
Mar 28, 2017

PAVmed to Present at the 16th Annual Needham Healthcare Conference

NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced that Lishan Aklog, M.D., PAVmed’s Chairman and Chief...
Mar 21, 2017

PAVmed Names Medical Device Industry Veteran Dennis M. McGrath as Chief Financial Officer

NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced that it has appointed Dennis M. McGrath as its new...
Mar 9, 2017

PAVmed Announces Closing of Additional Financing

Aggregate Private Placement Proceeds Exceed $2.5 Million

NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced the closing of approximately $1.0 million in additional...
Feb 23, 2017

PAVmed Announces Exchange Offer

Exchange to Provide Incentives for Long-Term Ownership by Existing and New Investors

NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW) announced today that the Company intends to effectuate a registered exchange offer (the “Exchange”) whereby PAVmed’s Common...
Feb 17, 2017

PAVmed to Hold Business Update Conference Call and Webcast on February 22nd

Fourth Quarter 2016 Financial Results Announced

NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM,PAVMW), a highly differentiated, multi-product medical device company, today announced financial results for the fourth quarter and year ended...
Feb 3, 2017

PAVmed Announces Warrants Now Exercisable for Cash

NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVM,PAVMW), a highly differentiated, multi-product medical device company, announced that at 4:00 pm today the Securities and Exchange Commission...
Feb 2, 2017

PAVmed Inc. Announces Closing of Financing

Company Considering Exchange Offers to Enhance Value of Outstanding Securities

NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced the closing of a $1.5 million financing. The private...
Dec 19, 2016

PAVmed Files 510(k) FDA Submission for PortIO™ Intraosseous Infusion System

First product regulatory submission marks major corporate milestone

NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM,PAVMW), a highly differentiated, multi-product medical device company, today announced that it has filed a 510(k) premarket notification...
Dec 2, 2016

PAVmed to Hold Business Update Conference Call and Webcast on December 7th

- Third Quarter 2016 Financial Results Announced -

NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVM,PAVMW), a highly differentiated, multi-product medical device company, today announced financial results for the third quarter ended September...
Nov 10, 2016

PAVmed to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum

NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVM), a highly differentiated, multi-product medical device company, today announced that Lishan Aklog, M.D., PAVmed’s Chairman and Chief...
Nov 4, 2016

PAVmed Partners with Leading Academic Institutions to Develop Revolutionary Ear Device

Agreement provides PAVmed with license to develop and commercialize antibiotic-eluting resorbable ear tube devices expected to benefit up to one million children per year

NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced that it has signed a definitive licensing agreement...

Show per page